PROFESSIONAL JOURNEY

Experience: 10 Years

-

CAREER HIGHLIGHTS

    • MBBS, DNB (Nuclear Medicine)
    • Fellowship European Board of Nuclear Medicine (FEBNM)
    • Fellowship Theranostics ( Germany)

     

MEMBERSHIPS

    • Fellow, European Board of Nuclear Medicine (FEBNM)
    • Life Member, Society of Nuclear Medicine India
    • Life Member, Association of Nuclear Medicine Physicians of India
    • Member, European Society of Medical Oncology
    • Member, European Neuroendocrine Tumor Society
    • Member, International Neuroendocrine Cancer Alliance
    • Member, Women in Nuclear Global

     

CLINICAL TRIALS & PUBLICATIONS

    1. The cost of neuroendocrine tumor patient healthcare: Comparison between advanced economies and emerging and developing economies. Abstract, October 2021, Journal of Clinical Oncology
    2. Treatments and ongoing monitoring for patients with neuroendocrine tumors, monitored by medical oncologists: Scan comparative data between advanced economies (AE) and emerging and developing economies (EDE). Abstract, May 2021, Journal of Clinical Oncology
    3. Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN): Global disparities in quality healthcare for NETs. Abstract,  October 2020, Journal of Clinical Oncology
    4. Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals, Journal of Nuclear Medicine Technology, October 2019
    5. Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas January 2019, Indian Journal of Nuclear Medicine 
    6. Dureja S et al. 213 Bi and Ac 225 DOTATOC Receptor Labeled Targeted Alpha-Radionuclide Therapy in Neuroendocrine Tumors Refractory to Beta Radiation - Early Experience, Abstract at 15th Annual ENETS Conference, 2018.
    7. Dosimetric analysis of patients with gastro-entero-pancreatic neuro endocrine tumors (NETs) treated with PRCRT (Peptide Receptor Chemo Radionuclide Therapy) using Lu-177 DOTATATE and Capecitabine/Temozolamide (CAP/TEM) July 2018, The British journal of Radiology 
    8. Rare sites of metastases in prostate cancer detected on Ga-68 PSMA PET/CT scan-a case series. January 2017, Indian Journal of Nuclear Medicine 
    9. Invited Lecture - Theranostics in NETS- from Imaging to Radioguided Surgery and Therapy, Annual Conference of Asia Pacific Neuroendocrine Tumor Society, October 2016, Malaysia
    10. Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study July 2014, European Spine Journal

Rated as Best Cancer Hospital in India